13.73 USD
↘ 0.36 (2.56%)AT CLOSE (11:59 AM EDT)
SELLAS Life Sciences Group, Inc. Common Stock
SLSNASDAQ • USD
13.77
↗ 0.04 (0.30%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
13.77
↗ 0.04 (0.30%)
Market: CLOSED
SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades at $13.73 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, SLS is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 26, 2026.
Open?$13.82
High?$13.92
Low?$13.41
Prev. Close?$14.09
Volume?4.6M
Avg. Volume?6.8M
VWAP?$13.66
Rel. Volume?0.68x
Bid / Ask
Bid?$13.79 × 700
Ask?$13.80 × 400
Spread?$0.01
Midpoint?$13.80
Valuation & Ratios
Market Cap?2.8B
Shares Out?201.9M
Float?199.3M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?20.14
EPS?-$0.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Themes
Employees
13
Market Cap
2.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
NEW YORK, NY 10036
Phone: (646) 200-5278
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?212.82Safe
Confidence?52%Low
Short InterestSqueeze Risk
Short % of Float?28.28%Squeeze Risk
Short Interest?56.4M
Days to Cover?10.4
Free Float199.3M
Avg Daily Volume5.4M
Settlement Date2026-08-14
Financial Health
Current Ratio?18.83Strong
Quick Ratio?18.83Strong
Cash Ratio?18.28Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?20.14HIGH▾
Peers100
S&P7
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-74.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-23.6%WEAK▾
S&P7
ROA?-22.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28423000
Enterprise Value?$2.6B
Fundamentals ratios updated end of day